Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Bayer reports LTB4 synthesis inhibitors for asthma

Aug. 12, 1997

First European clinical trials of pranlukast reported

Aug. 11, 1997

Orally active PDE IV inhibitors from Merck Frosst

Aug. 11, 1997

Allegra now available in Canada

Aug. 6, 1997

Anti-IL-4 MAb effective in murine model of asthma

Aug. 5, 1997

Leukotriene synthesis inhibitors in development at Bayer

Aug. 5, 1997

Nonpeptide NK3 antagonists from SmithKline Beecham

Aug. 5, 1997

HMR discovers elastase inhibitors and prodrugs thereof

July 31, 1997

Device for snoring cleared by FDA

July 30, 1997

JTV-506 shows potential for asthma

July 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...